Open Access. Powered by Scholars. Published by Universities.®
- Discipline
- File Type
Articles 1 - 7 of 7
Full-Text Articles in Medicine and Health Sciences
A New Treatment For Psychosis In Parkinson’S Disease, Kevin J. Black
A New Treatment For Psychosis In Parkinson’S Disease, Kevin J. Black
Kevin J. Black, MD
Parkinson’S Disease Psychosis: A Roundtable Discussion, Jennifer G. Goldman, Rajesh Pahwa, Stuart H. Isaacson, Kevin J. Black
Parkinson’S Disease Psychosis: A Roundtable Discussion, Jennifer G. Goldman, Rajesh Pahwa, Stuart H. Isaacson, Kevin J. Black
Kevin J. Black, MD
Depression In Parkinson Disease, Kevin J. Black
Depression In Parkinson Disease, Kevin J. Black
Kevin J. Black, MD
A Fixed-Dose Randomized Controlled Trial Of Olanzapine For Psychosis In Parkinson Disease, Michelle J. Nichols, Johanna M. Hartlein, Meredith Ga Eicken, Brad A. Racette, Kevin J. Black
A Fixed-Dose Randomized Controlled Trial Of Olanzapine For Psychosis In Parkinson Disease, Michelle J. Nichols, Johanna M. Hartlein, Meredith Ga Eicken, Brad A. Racette, Kevin J. Black
Kevin J. Black, MD
Background: Psychosis is a common and debilitating side effect of long-term dopaminergic treatment of Parkinson disease (PD). While clozapine is an effective treatment, the need for blood monitoring has limited its first-line use.
Objective: Since olanzapine shows similar receptor affinity to clozapine, we hypothesized that it might be an effective alternative to clozapine for treatment of drug-induced psychosis (DIP) in PD, and that lower doses than usual might make it tolerable.
Methods: In 1998-2003 we conducted a four-week, double-blind, placebo-controlled, parallel group, fixed-dose trial of olanzapine (0, 2.5mg, or 5mg) in 23 PD patients with DIP while allowing for clinically …
Hallucinations—Psychosis Related To Parkinson’S Disease, Kevin J. Black
Hallucinations—Psychosis Related To Parkinson’S Disease, Kevin J. Black
Kevin J. Black, MD
No abstract provided.
Neuropsychiatry Of Movement Disorders, Kevin J. Black, Jonathan W. Mink
Neuropsychiatry Of Movement Disorders, Kevin J. Black, Jonathan W. Mink
Kevin J. Black, MD
Movement disorders include both psychiatric illnesses with neurologic features and neurologic illnesses with frequent psychiatric complications. During 1998, neuropsychiatric progress was made on several fronts, notably in parkinsonism and tic disorders. This remains an exciting area for research, with many unsolved, clinically important problems, but with increasing neurobiologic knowledge and sophistication.
Depression In Pd, Kevin J. Black